EMERYVILLE, Calif., Aug. 21, 2024 /PRNewswire/ -- Kyverna Therapeutics, Inc. (Kyverna), a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases, announced today that the company's executives will participate in the following investor events:Investor Conference Details:    Morgan Stanley Global Healthcare Conference in New York, NY on September 4, 2024Format: Fireside Chat with Mike Ulz at 11:30 am EDT and host investor ...